Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Portfolio Management Symposium

Session Chair(s)

Gregg  Schneider

Gregg Schneider

Director, R&D Financial Management

Otsuka Pharmaceutical Development & Commercialization, Inc., United States

Adopting an Adaptive Design Strategy to Manage Portfolio Risk and Value

Learning Objective : Assess adaptive design options at each phase of development; Discuss the specifics of portfolio planning for a generic company.

Speaker(s)

Sarah  Arbe-Barnes, PhD

Adopting an Adaptive Design Strategy to Manage Portfolio Risk and Value

Sarah Arbe-Barnes, PhD

Aptiv Solutions, United States

Vladimir M Shnaydman, PhD, MSc

Portfolio Optimization for a Generic Drug Company

Vladimir M Shnaydman, PhD, MSc

ORBee Consulting, United States

President

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.